2-amino-1,8-naphthyridine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 4173048 |
| SCHEMBL ID | 169378 |
| MeSH ID | M0388705 |
| Synonym |
|---|
| 1,8-naphthyridin-2-amine |
| 15992-83-3 |
| FT-0651056 |
| F1957-0082 |
| AKOS002665378 |
| A810088 |
| AB08428 |
| SCHEMBL169378 |
| iminonaphthyridin |
| p-toluenesulfonicacid1-butyn-3-ylester |
| [1,8]naphthyridin-2-ylamine |
| 2-amino-1,8-naphthyridine |
| [1,8]-naphthyridin-2-ylamine |
| CRADWWWVIYEAFR-UHFFFAOYSA-N |
| DS-1801 |
| DTXSID20400260 |
| mfcd01250851 |
| CS-W021294 |
| BCP04700 |
| aminonaphthyridine |
| EN300-1197910 |
| SY023915 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.65) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 15 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||